Based on the observations, that deregulated and hyperacetylated proteins are involved in cell cycle, oncogenic signaling and DNA damage response and that HDACi treatments result in increased DNA damage and apoptosis in ALCL cells, HDAC inhibition could be considered as a possible therapeutic intervention for patients suffering from these malignancies. Here, HDAC9 is linked to anaplastic large cell lymphoma.